Beruflich Dokumente
Kultur Dokumente
CBE 023 V2
Module Topics
Fundamental EM Program what to monitor
CBE 023 V2
Introduction
CBE 023 V2
CBE 023 V2
WHO Guidance
Environmental Monitoring of Clean Rooms in Vaccine Facilities
Points to consider for manufacturers of human vaccines
CBE 023 V2
Why do we monitor ?
Particulates: Verify that the HVAC systems is functioning
correctly and rooms are meeting specifications. Particles are
associated with physical contamination and indirectly microbiological contamination.
CBE 023 V2
Particles at rest
Temperature
Relative Humidity
Room Pressures
Biological
Bacteria
Yeast and moulds
Pharmaceutical Services
Water system and in some cases steam
HVAC
Pharmaceutical gases
CBE 023 V2
CBE 023 V2
CBE 023 V2
10
Grade B Space
Proximal to air returns
Door handles (swabs)
Obstacles that may create
turbulence (air)
Trolleys
HMI Consoles
Floor / Walls/Windows
Pass throughs
Adjustment tools
CBE 023 V2
Environmental Monitoring
11
CBE 023 V2
12
13
14
(2) The practice of air sampling at the start, middle, and end of filling operations provides
better environmental monitoring and facilitates investigations related to filling batch
release. This approach should be part of a general environmental monitoring strategy
based on risk analysis and considering the types of activities performed.
CBE 023 V2
15
Room Activity
No Product / Materials Exposed
Processing Equipment Storage
Packaging Areas
Open Product Exposed
CBE 023 V2
Liquid / Creams
I
II
II
III
16
Yeast Mold
> 25
> 15
CBE 023 V2
Action Limit
Total
Count
> 40
Bacteria
Yeast Mold
> 50
> 30
Total
Count
> 100
17
The Paperwork
Sample Location
Date sample taken (length of time for settle plates)
Batch number and expiry of the media
Operator(s) who took the samples
State of the room (at rest or in operation and activity)
Incubation conditions
Operator reading the plates and date read
Number of cfu per sample separate for Yeast / Mold
Any identification
Signature of person reviewing the results
CBE 023 V2
18
Physical Monitoring
Pressure Differentials
Generally continuous by a validated EMS
or
Temperature / RH %
Either EMS system or in- room physical monitors
Record Max and Min per day
Filter Integrity
Annual clean and test for % penetration
Velocity not usually measured for non-sterile rooms, except for validation
purposes / air change rate calculations.
CBE 023 V2
19
CBE 023 V2
20
Pharmaceutical Waters
21
CBE 023 V2
22
23
Water Sampling
Must have a water system map with numbered
sampling valves for up stream and points of use (POU)
Pre-clean outlet with 70% alcohol. (TOC sample last.)
CBE 023 V2
24
Water Standards
British and European Pharmacopoeia monographs
United States Pharmacopoeia <1231>
CPMP/QWP/158/01 Guidance Quality of water for
pharmaceutical use
CBE 023 V2
25
CBE 023 V2
26
Expected Limits
Purified
Water
WFI
CBE 023 V2
27
CBE 023 V2
28
Oversight by QC Microbiology
QC Led Team
Independent of Production
Policeman approach
Not efficient utilisation of
resources
Pragmatic approach
In-process control
Must have strong QC oversight
Training of operators
QC surveillance program
Random audits by QC
CBE 023 V2
29
Core EM Documentation
Location Maps
Trend Monitoring
EM Isolates Program
surface recovery studies
Method Validation
Incubator qualification
Training
Test Methods
Sampling forms
Incubation / Results
Gown Validation
Other
Media Growth Promotion
CBE 023 V2
Vendor Audits
Receipt Testing
30
Environmental Monitoring
31
Environmental Monitoring
32
CBE 023 V2
33
7.
8.
9.
CBE 023 V2
34
Must also consider risk to product associated with the sampling itself
Must be able to remove any media residue from surfaces
CBE 023 V2
35
Passive Air
Surface
Personal
(Settle 4 hr)
(Rodac/Swab)
(Glove 5 finger)
A<1
A<1
A<1
A<1
B 10
B5
B5
B5
US FDA
Class 100
Not
specified
Not
specified
Not
specified
Class 10,000
10
ISO 5 <1%
ISO 7 <5%
Same
incident rate
as active air
Same
incident rate
as active air
Same
incident rate
as active air
Same
incident rate
as active air
A<1
A<1
A<1
A<1
Not
specified
B 10
B5
B5
B5
EU/PICs/Who
Annex 1
USP <1116>
(incident rate)
Japan
Aseptic Guide
(JPXV1)
CBE 023 V2
Personal
(Gown)
Not
specified
36
Passive Air
Surface
Personal
(Settle 4 hr)
(Rodac/Swab)
(Glove 5 finger)
Personal
(Gown)
C 100
C 50
C 25
Not
specified
EU/PICs/Who
Annex 1
D 200
D 100
D 50
Not
specified
US FDA
Class 100,000
100
50
Not
specified
Not
specified
Not
specified
USP <1116>
(incident rate)
ISO 8
<10%
Same
incident rate
as active air
Same
incident rate
as active air
Same
incident rate
as active air
Same
incident rate
as active air
Japan
C 100
C 50
C 25
Not
specified
Not
specified
Aseptic Guide
(JPXV1)
CBE 023 V2
D 200
D 100
D 50
37
Grade B Profile
14
12
10
8
6
4
2
0
1
10
Count (B)
11
12
13
14
15
16
17
18
Limit
19
20
Grade B Profile
12
10
8
6
4
2
0
1
10 11 12 13 14 15 16 17 18 19 20
Count (B)
CBE 023 V2
Limit
38
39
CBE 023 V2
40
CBE 023 V2
41
CBE 023 V2
42
43
Rank
Percent
59
33
22
18
18
18
17
16
14
12
11
11
10
10
10
etc .
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
etc ..
100.0%
97.9%
95.9%
93.8%
91.8%
89.7%
87.7%
85.7%
83.6%
81.6%
79.5%
77.5%
75.5%
73.4%
71.4%
CBE 023 V2
Action @ 95%
Alert @ 90%
44
Action Limit
Alert Limit
CBE 023 V2
45
Any result
Any result
exceeds the
action limit
CBE 023 V2
Inspect the cleaning record for the equipment to verify it was properly
cleaned and sanitized
CBE 023 V2
47
Environmental Monitoring:
Relationship to Batch Release
While an inferential relationship exists between microbiological
environmental monitoring data and batch release, reaching or exceeding
and action level does not necessarily indicate that product quality is
adversely affected.
CBE 023 V2
Environmental Monitoring
48
Filling Room #
1
Filling Room #
1 Vial Storage
Filling Room
#2
Active Air
561
187
19
Passive Air
561
19
Surface
Total EM Samples
1587
2659
187
0
Type of
Monitoring
Number Positives
Active Air
Passive Air
Surface
Total EM Samples
Number Positives
CBE 023 V2
374
56
94
561
0
38
19
2171
220
2732
277
49
CBE 023 V2
50
CBE 023 V2
51
CBE 023 V2
52
and
CBE 023 V2
53
CBE 023 V2
54
CBE 023 V2
55
Grade A
Critical Space and Critical Surfaces
Critical Space Grade A / ISO 5
A critical area is one in which the sterilized drug product, containers, and
closures are exposed to environmental conditions that must be designed to
maintain product sterility.
Critical Surfaces within Critical Space
Not all Grade A space is a critical surface.
Surfaces that may come into contact with or directly affect a sterilized
product or its containers or closures.
Critical surfaces are rendered sterile prior to the start of the manufacturing
operation, and sterility is maintained throughout processing. Generally
monitored post processing.
CBE 023 V2
56
CBE 023 V2
57
Gloves
Initial qualification
End of aseptic session / end of shift in rotation
Post entry into Grade A space for all high risk interventions
Left and right hands 5 fingers
CBE 023 V2
58
CBE 023 V2
59
60
CBE 023 V2
61
62
Case Example # 1
No sterility failures
No media fill fails
Excellent history of EMs in last 2 years
Operators are qualified and well trained
Investigation
Source
Fate of the batch
Corrective Action(s)
CBE 023 V2
63
CBE 023 V2
64
In summary
EM is expensive and outcomes can be problematic
Must pay attention to the small details
65
Steve Williams,
Director, CBE Pty Ltd
www.cbe-ap.com.au
+61(0)417116476
steve.williams@cbe-ap.com.au
CBE 023 V2